Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.9 |
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.9 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |
mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |